Spots Global Cancer Trial Database for Study to Evaluate the Efficacy and Safety of Treatment With Bendamustine in Combination With Ofatumumab in Previously Untreated Patients With Indolent B-Cell Non-Hodgkin's Lymphoma (NHL)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study to Evaluate the Efficacy and Safety of Treatment With Bendamustine in Combination With Ofatumumab in Previously Untreated Patients With Indolent B-Cell Non-Hodgkin's Lymphoma (NHL)
Official Title: An Open-Label Study to Evaluate the Efficacy and Safety of Treatment With Bendamustine in Combination With Ofatumumab in Previously Untreated Patients With Indolent B-Cell Non-Hodgkin's Lymphoma (NHL)
Study ID: NCT01108341
Conditions
Study Description
Brief Summary: The primary objective of the study is to determine the efficacy, as measured by overall response (complete response + partial response) of bendamustine in combination with ofatumumab in previously untreated patients with indolent B-Cell Non-Hodgkin's Lymphoma (NHL).
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Birmingham Hematology and Oncology Associates, LLC, Birmingham, Alabama, United States
University of Alabama at Birmingham, Birmingham, Alabama, United States
Tower Cancer Research Foundation, Beverly Hills, California, United States
Hematology Oncology, P.C., Stamford, Connecticut, United States
University Cancer Institute, Boynton Beach, Florida, United States
Florida Cancer Institute - New Hope, New Port Richey, Florida, United States
Dublin Hematology Oncology Care P.C., Dublin, Georgia, United States
Northwest Georgia Oncology Center, Marietta, Georgia, United States
Georgia Cancer Specialists, Tucker, Georgia, United States
Cancer Care and Hematology Specialists of Chicagoland, Niles, Illinois, United States
Siouxland Hematology-Oncology Assoc. LLP, Sioux City, Iowa, United States
Kentucky Cancer Clinic, Hazard, Kentucky, United States
Carroll County Cancer Center, Westminster, Maryland, United States
Columbia Comprehensive Cancer Care Clinic, Jefferson City, Missouri, United States
Nevada Cancer Institute, Las Vegas, Nevada, United States
Somerset Hematology Oncology Associates, Somerville, New Jersey, United States
Roswell Park Cancer Institute, Buffalo, New York, United States
Monter Cancer Center, Lake Success, New York, United States
Mid Dakota Clinic, Bismarck, North Dakota, United States
Oregon Health Sciences University, Portland, Oregon, United States
University of Pittsburgh Medical Center - Cancer Institute, Pittsburgh, Pennsylvania, United States
Cancer Centers of the Carolinas, Greenville, South Carolina, United States
The West Clinic, Memphis, Tennessee, United States
Texas Oncology, P.A., Bedford, Texas, United States
MD Anderson Cancer Center, Houston, Texas, United States
Longview Cancer Center, Longview, Texas, United States
Joe Arrington Cancer Research, Lubbock, Texas, United States
Texas Oncology, P.A., McAllen, Texas, United States
Cancer Care Centers of South Texas, San Antonio, Texas, United States
Texas Oncology, Waco, Texas, United States
Texas Oncology, P.A., Webster, Texas, United States
US Oncology Research - Texoma Cancer Center, Wichita Falls, Texas, United States
Fairfax/Northern Virginia Hematology/Oncology, Fairfax, Virginia, United States
Yakima Valley Memorial Hospital/North Start Lodge, Yakima, Washington, United States
Cephalon Investigational Site, Bruxelles, , Belgium
Cephalon Investigational Site, Bruxelles, , Belgium
Cephalon Investigational Site, Gent, , Belgium
Cephalon Investigational Site, Haifa, , Israel
Cephalon Investigational Site, Nahariya, , Israel
Contact Details
Name: Sponsor's Medical Expert
Affiliation: Cephalon
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
